News

Dr. Freek Beekman Visits Imanis!

Dr. Freek Beekman Visits Imanis!

Imanis is excited to release a new video series showcasing our connections with leaders in the field of preclinical in vivo imaging, starting with Dr. Freek Beekman! We welcomed Dr. Freek Beekman to...

Dr. Freek Beekman Visits Imanis!

Imanis is excited to release a new video series showcasing our connections with leaders in the field of preclinical in vivo imaging, starting with Dr. Freek Beekman! We welcomed Dr. Freek Beekman to...

In Vivo Tumor Progression Studies: An Education...

On June 8, Dr. Kah-Whye Peng, COO of Imanis Life Sciences, co-presented a webinar entitled “In Vivo Tumor Progression Imaging Studies” with Dr. Andrew Van Praagh, Bruker Biospin Field Applications...

In Vivo Tumor Progression Studies: An Education...

On June 8, Dr. Kah-Whye Peng, COO of Imanis Life Sciences, co-presented a webinar entitled “In Vivo Tumor Progression Imaging Studies” with Dr. Andrew Van Praagh, Bruker Biospin Field Applications...

ASCO Update: Oncolytic virotherapy with immune ...

Virotherapy in combination with immune modulators such as checkpoint inhibitors at ASCO-SITC. Presentation by Dr. Stephen Russell, Mayo Clinic.

ASCO Update: Oncolytic virotherapy with immune ...

Virotherapy in combination with immune modulators such as checkpoint inhibitors at ASCO-SITC. Presentation by Dr. Stephen Russell, Mayo Clinic.

Imanis Life Sciences Launches Line of Oncolytic...

Filling a market need for commercially available oncolytic vaccinia virus   ROCHESTER, Minn., February 23, 2017 — Imanis Life Sciences announced today the launch of a new product line of...

Imanis Life Sciences Launches Line of Oncolytic...

Filling a market need for commercially available oncolytic vaccinia virus   ROCHESTER, Minn., February 23, 2017 — Imanis Life Sciences announced today the launch of a new product line of...

NEW human NIS with enhanced TFB uptake for supe...

Imanis is proud to announce the launch of a new line of NIS specifically tailored for PET imaging using the high sensitive tracer F18-tetrafluoroborate. This new NIS, NISplus, has been...

NEW human NIS with enhanced TFB uptake for supe...

Imanis is proud to announce the launch of a new line of NIS specifically tailored for PET imaging using the high sensitive tracer F18-tetrafluoroborate. This new NIS, NISplus, has been...

HSV oncolytic reporter gene NIS GFP Imanis

NEW: Oncolytic recombinant herpes simplex virus...

Imanis is pleased to announce the availability of three new recombinant HSV-1 viruses encoding reporter genes for use in in vitro and in vivo studies. These ready to use HSV-1...

NEW: Oncolytic recombinant herpes simplex virus...

Imanis is pleased to announce the availability of three new recombinant HSV-1 viruses encoding reporter genes for use in in vitro and in vivo studies. These ready to use HSV-1...